→Appendix 1: aprepitant
PDF page 475
▶Common or very common Appetite decreased. asthenia.
constipation. gastrointestinal discomfort. headache.
hiccups
▶Uncommon Anaemia. anxiety. burping. dizziness.
drowsiness. dry mouth. febrile neutropenia.
gastrointestinal disorders. hot flush. malaise. nausea.
palpitations. skin reactions. urinary disorders. vomiting
▶Rare or very rare Bradycardia. cardiovascular disorder.
chest discomfort. cognitive disorder. conjunctivitis.
cough. disorientation. euphoric mood. gait abnormal.
hyperhidrosis. increased risk of infection. muscle spasms.
muscle weakness. oedema. oropharyngeal pain.
photosensitivity reaction. polydipsia. seborrhoea. severe
cutaneous adverse reactions (SCARs). sneezing.
stomatitis. taste altered. throat irritation. tinnitus.
weight decreased
▶Frequency not known Dysarthria. dyspnoea. insomnia.
miosis. sensation abnormal. visual acuity decreased.
wheezing
PDF page 475
Manufacturer advises
effectiveness of hormonal contraceptives may be
reduced—alternative non-hormonal methods of
contraception necessary during treatment and for
2 months after stopping aprepitant.
PDF page 475
Manufacturer advises avoid unless clearly
necessary—no information available.
PDF page 475
Manufacturer advises avoid—present in
milk in animal studies.
PDF page 475
Manufacturer advises caution in
moderate to severe impairment—limited information
available.
PDF page 475